Compare MX & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MX | BHST |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | South Korea | Canada |
| Employees | N/A | 87 |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.4M | 97.7M |
| IPO Year | 2007 | N/A |
| Metric | MX | BHST |
|---|---|---|
| Price | $2.87 | $4.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.75 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 278.6K | 19.4K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $178,860,000.00 | N/A |
| Revenue This Year | $8.55 | $146.27 |
| Revenue Next Year | $6.37 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $4.10 |
| 52 Week High | $4.50 | $12.80 |
| Indicator | MX | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 43.51 |
| Support Level | $2.56 | $4.19 |
| Resistance Level | $3.02 | $4.96 |
| Average True Range (ATR) | 0.15 | 0.21 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 46.95 | 18.84 |
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.